Respiratory System |
Human lung epithelial cells BEAS-2B |
Decrease α1-antitrypsin levels |
90,91,93 |
Induce IL-6 and IL-8 expression |
Human alveolar type II epithelial A549 and BEAS-2B |
Induce senescence |
92,93 |
Increase ROS generation and pro-inflammatory state |
A549 |
Induce apoptosis increasing BAX, caspase-3, caspase-8, caspase-9 and cytochrome c |
93 |
Induce cell cycle S phase arrest |
BEAS-2B and human pulmonary alveolar epithelial cells HPAEpiC |
Decrease cell viability and induce redox imbalance |
94 |
Increase levels of MMP9 and surfactant protein A |
Immunitary System |
Human monocytes |
Pro-inflammatory cytokines release |
96 |
Hematopoietic stem cells |
Decrease survival and proliferation |
81 |
Human Peripheral blood mononuclear cell PBMCs |
Induce IL-6 and TNF-α production |
97 |
Renal system |
Human kidney HK-2 cells |
Increase ROS levels |
99 |
Increase Bad and decrease Bcl-2 protein levels |
Increase ER stress-and autophagy |
Increase MAPK and AKT/mTOR signaling pathways |
HK-2 cells |
Increase extracellular vesicles |
100 |
Embryonic kidney cells HEK 293 |
Decrease cell viability |
101 |
Increase oxidative stress |
Decrease ATP production |
Increase TNF, IL-6, caspase 3 and caspase 9 gene expression |